Chalepin and Chalepensin: Occurrence, Biosynthesis and Therapeutic Potential

Dihydrofuranocoumarin, chalepin (<b>1</b>) and furanocoumarin, chalepensin (<b>2</b>) are 3-prenylated bioactive coumarins, first isolated from the well-known medicinal plant <i>Ruta chalepensis</i> L. (Fam: Rutaceae) but also distributed in various species of the...

Full description

Bibliographic Details
Main Authors: Lutfun Nahar, Shaymaa Al-Majmaie, Afaf Al-Groshi, Azhar Rasul, Satyajit D. Sarker
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/26/6/1609
_version_ 1797541395985072128
author Lutfun Nahar
Shaymaa Al-Majmaie
Afaf Al-Groshi
Azhar Rasul
Satyajit D. Sarker
author_facet Lutfun Nahar
Shaymaa Al-Majmaie
Afaf Al-Groshi
Azhar Rasul
Satyajit D. Sarker
author_sort Lutfun Nahar
collection DOAJ
description Dihydrofuranocoumarin, chalepin (<b>1</b>) and furanocoumarin, chalepensin (<b>2</b>) are 3-prenylated bioactive coumarins, first isolated from the well-known medicinal plant <i>Ruta chalepensis</i> L. (Fam: Rutaceae) but also distributed in various species of the genera <i>Boenminghausenia</i>, <i>Clausena</i> and <i>Ruta</i>. The distribution of these compounds appears to be restricted to the plants of the family Rutaceae. To date, there have been a considerable number of bioactivity studies performed on coumarins <b>1</b> and <b>2</b>, which include their anticancer, antidiabetic, antifertility, antimicrobial, antiplatelet aggregation, antiprotozoal, antiviral and calcium antagonistic properties. This review article presents a critical appraisal of publications on bioactivity of these 3-prenylated coumarins in the light of their feasibility as novel therapeutic agents and investigate their natural distribution in the plant kingdom, as well as a plausible biosynthetic route.
first_indexed 2024-03-10T13:15:24Z
format Article
id doaj.art-6694c890c14f4495b5cb31f87beee46f
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T13:15:24Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-6694c890c14f4495b5cb31f87beee46f2023-11-21T10:26:31ZengMDPI AGMolecules1420-30492021-03-01266160910.3390/molecules26061609Chalepin and Chalepensin: Occurrence, Biosynthesis and Therapeutic PotentialLutfun Nahar0Shaymaa Al-Majmaie1Afaf Al-Groshi2Azhar Rasul3Satyajit D. Sarker4Laboratory of Growth Regulators, Institute of Experimental Botany ASCR and Palacký University, Šlechtitelů 27, 78371 Olomouc, Czech RepublicCentre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, UKCentre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, UKCell and Molecular Biology Lab, Department of Zoology, Government College University, Faisalabad 38000, PakistanCentre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, UKDihydrofuranocoumarin, chalepin (<b>1</b>) and furanocoumarin, chalepensin (<b>2</b>) are 3-prenylated bioactive coumarins, first isolated from the well-known medicinal plant <i>Ruta chalepensis</i> L. (Fam: Rutaceae) but also distributed in various species of the genera <i>Boenminghausenia</i>, <i>Clausena</i> and <i>Ruta</i>. The distribution of these compounds appears to be restricted to the plants of the family Rutaceae. To date, there have been a considerable number of bioactivity studies performed on coumarins <b>1</b> and <b>2</b>, which include their anticancer, antidiabetic, antifertility, antimicrobial, antiplatelet aggregation, antiprotozoal, antiviral and calcium antagonistic properties. This review article presents a critical appraisal of publications on bioactivity of these 3-prenylated coumarins in the light of their feasibility as novel therapeutic agents and investigate their natural distribution in the plant kingdom, as well as a plausible biosynthetic route.https://www.mdpi.com/1420-3049/26/6/1609<i>Ruta chalepensis</i>Rutaceaechalepinchalepensinbioactivitybiosynthesis
spellingShingle Lutfun Nahar
Shaymaa Al-Majmaie
Afaf Al-Groshi
Azhar Rasul
Satyajit D. Sarker
Chalepin and Chalepensin: Occurrence, Biosynthesis and Therapeutic Potential
Molecules
<i>Ruta chalepensis</i>
Rutaceae
chalepin
chalepensin
bioactivity
biosynthesis
title Chalepin and Chalepensin: Occurrence, Biosynthesis and Therapeutic Potential
title_full Chalepin and Chalepensin: Occurrence, Biosynthesis and Therapeutic Potential
title_fullStr Chalepin and Chalepensin: Occurrence, Biosynthesis and Therapeutic Potential
title_full_unstemmed Chalepin and Chalepensin: Occurrence, Biosynthesis and Therapeutic Potential
title_short Chalepin and Chalepensin: Occurrence, Biosynthesis and Therapeutic Potential
title_sort chalepin and chalepensin occurrence biosynthesis and therapeutic potential
topic <i>Ruta chalepensis</i>
Rutaceae
chalepin
chalepensin
bioactivity
biosynthesis
url https://www.mdpi.com/1420-3049/26/6/1609
work_keys_str_mv AT lutfunnahar chalepinandchalepensinoccurrencebiosynthesisandtherapeuticpotential
AT shaymaaalmajmaie chalepinandchalepensinoccurrencebiosynthesisandtherapeuticpotential
AT afafalgroshi chalepinandchalepensinoccurrencebiosynthesisandtherapeuticpotential
AT azharrasul chalepinandchalepensinoccurrencebiosynthesisandtherapeuticpotential
AT satyajitdsarker chalepinandchalepensinoccurrencebiosynthesisandtherapeuticpotential